| Description | Zimberelimab, a fully human IgG4 monoclonal antibody targeting PD-1 with high affinity and selectivity, exhibits antitumor activities. It is applicable in research on various cancers, including cervical cancer, non-small cell lung cancer, and classical Hodgkin’s lymphoma [1]. |
| molecular weight | N/A |
| CAS | 2259860-24-5 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |